drug · small molecule
ixazomib citrate
Marketedupdated 5mo agoby Millennium Pharmaceuticals Inc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple myeloma and amyloidosis and 7 investigational indications.
targets
26S proteasome
all catalysts(0)
nothing on the calendar yet
Trials studying ixazomib citrate
- phase2Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
- phase1SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
- phase2Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
- phase3A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant
- phase2Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 6, 2027
310 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (21)
- Nov 20, 2029compositionUS 74428303.1y
- Nov 20, 2029compositionUS 74428303.1y
- Nov 20, 2029compositionUS 74428303.1y
- Jun 16, 2029compositionUS 88595042.7y
- Jun 16, 2029compositionUS 88595042.7y
- Jun 16, 2029compositionUS 88595042.7y
- Jun 16, 2029method-of-use (U-2434)US 91750172.7y
- Jun 16, 2029method-of-use (U-2434)US 91750172.7y
- Jun 16, 2029method-of-use (U-2434)US 91750172.7y
- Aug 6, 2027compositionUS 7687662310d
- Aug 6, 2027compositionUS 7687662310d
- Aug 6, 2027compositionUS 7687662310d
- Aug 6, 2027compositionUS 8003819310d
- Aug 6, 2027compositionUS 8003819310d
- Aug 6, 2027compositionUS 8003819310d
- Aug 6, 2027compositionUS 8530694310d
- Aug 6, 2027compositionUS 8530694310d
- Aug 6, 2027compositionUS 8530694310d
- Aug 6, 2027method-of-use (U-2434)US 8871745310d
- Aug 6, 2027method-of-use (U-2434)US 8871745310d
- Aug 6, 2027method-of-use (U-2434)US 8871745310d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that